Published in
Elsevier, European Urology, 5(79), p. 659-662, 2021
DOI: 10.1016/j.eururo.2020.06.021
Links
Tools
Atezolizumab plus Bevacizumab Versus Sunitinib for Patients with Untreated Metastatic Renal Cell Carcinoma and Sarcomatoid Features: A Prespecified Subgroup Analysis of the IMmotion151 Clinical Trial
Journal article published in 2020 by
Brian I. Rini 
,
Robert J. Motzer,
Thomas Powles,
David F. McDermott,
Bernard Escudier,
Frede Donskov,
Robert Hawkins,
Sergio Bracarda,
Jens Bedke,
Ugo De Giorgi ,
Camillo Porta,
Alain Ravaud,
Francis Parnis,
Enrique Grande,
Wei Zhang
and other authors.
,
Robert J. Motzer,
Thomas Powles,
David F. McDermott,
Bernard Escudier,
Frede Donskov,
Robert Hawkins,
Sergio Bracarda,
Jens Bedke,
Ugo De Giorgi ,
Camillo Porta,
Alain Ravaud,
Francis Parnis,
Enrique Grande,
Wei Zhang
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 